MedPath

ow-dose aspirin for reduction in preeclampsia risk in high-risk women in Japan.

Not Applicable
Conditions
preeclampsia
Registration Number
JPRN-UMIN000020013
Lead Sponsor
Osaka Medical Center and Research Institute for Maternal and Child Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

1 multiple pregnancy 2 non-Japanease 3 low-dose aspirin initiated under 12 weeks'gestation for other reason 4 women who are out of sympathy with a plan

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the incidence of preeclampsia in high-risk women(previous preeclampsia,chronic hypertension,diabetes,autoimmune disease,blood pressure>130/80 at the first visit and BMI greater than 35)
Secondary Outcome Measures
NameTimeMethod
the incidence of severe preeclampsia,preterm labor and fetal growth restriction in high-risk women
© Copyright 2025. All Rights Reserved by MedPath